A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number

p16 Expression Differentiates High-Risk Gastrointestinal Stromal Tumor and Predicts Poor Outcome

(2015) Michael Schmieder et al.   NEOPLASIA

The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors

(2011) Martin G. Belinsky et al.   CELL CYCLE

High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors

(2009) Martin G. Belinsky et al.   GENES CHROMOSOMES & CANCER

Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target

(2009) Maria A. Pantaleo et al.   INTERNATIONAL JOURNAL OF CANCER

Deletions of Chromosome 1p and 15q are Associated with Aggressiveness of Gastrointestinal Stromal Tumors

(2009) Yi Chen et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Acetylation of RTN-1C regulates the induction of ER stress by the inhibition of HDAC activity in neuroectodermal tumors

(2009) B Fazi et al.   ONCOGENE

Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review)

(2009) Maleddu   ONCOLOGY REPORTS

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

(2008) C. Braconi et al.   ANNALS OF ONCOLOGY

Genetic aberrations of gastrointestinal stromal tumors

(2008) Jilong Yang et al.   CANCER

Dapper1 Is a Nucleocytoplasmic Shuttling Protein That Negatively Modulates Wnt Signaling in the Nucleus

(2008) Xia Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

(2008) C. Tarn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA